The cross-talk between FTH1 and PYCR1 drives pancreatic cancer progression.

被引：0
|
作者：
Park, Ji Min [1 ]
Chiu, Ching-Feng [1 ]
机构：
[1] Taipei Med Univ, Taipei, Taiwan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6378
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The cross-talk between FTH1 & PYCR1 plays a pivotal role in driving the progression of KRAS-mutated pancreatic cancer
    Park, Jimin
    Qiu, Yuankai
    Su, Yenhao
    Chen, Hsinan
    Lee, Alanyueh L.
    Chang, Jungsu
    Kuo, Chengchin
    Chiu, Chingfeng
    CANCER SCIENCE, 2024, 115 : 1289 - 1289
  • [2] Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells
    Park, Ji Min
    Su, Yen-Hao
    Fan, Chi-Shuan
    Chen, Hsin-Hua
    Qiu, Yuan-Kai
    Chen, Li-Li
    Chen, Hsin-An
    Ramasamy, Thamil Selvee
    Chang, Jung-Su
    Huang, Shih-Yi
    Chang, Wun-Shaing Wayne
    Lee, Alan Yueh-Luen
    Huang, Tze-Sing
    Kuo, Cheng-Chin
    Chiu, Ching-Feng
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (09): : 2065 - 2081
  • [3] Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells (vol 56, pg 2065, 2024)
    Park, Ji Min
    Su, Yen-Hao
    Fan, Chi-Shuan
    Chen, Hsin-Hua
    Qiu, Yuan-Kai
    Chen, Li-Li
    Chen, Hsin-An
    Ramasamy, Thamil Selvee
    Chang, Jung-Su
    Huang, Shih-Yi
    Chang, Wun-Shaing Wayne
    Lee, Alan Yueh-Luen
    Huang, Tze-Sing
    Kuo, Cheng-Chin
    Chiu, Ching-Feng
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2025, : 700 - 701
  • [4] AIF1 drives tumor progression via a cellular cross-talk with the tumor microenvironment
    Cao, C.
    Yu, R.
    Xia, Y.
    Liu, D.
    Gao, Q.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 146 - 146
  • [5] Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells
    Russo, Matteo Antonio
    Ravenna, Linda
    Pellegrini, Laura
    Petrangeli, Elisa
    Salvatori, Luisa
    Magrone, Thea
    Fini, Massimo
    Tafani, Marco
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2016, 16 (04) : 235 - 248
  • [6] MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer
    Xu, Haixia
    He, Yan
    Lin, Lin
    Li, Meixiang
    Zhou, Zeqiang
    Yang, Yi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 575 : 56 - 64
  • [7] Targeting NDRG1 to inhibit bidirectional oncogenic cross-talk between pancreatic cancer and stroma
    Geleta, Bekesho
    Park, Kyung Chan
    Jansson, Patric J.
    Sahni, Sumit
    Apte, Minoti
    Richardson, Des
    Kovacevic, Zaklina
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 13 - 14
  • [8] Paracrine cross-talk between pancreatic cancer cells and periacinar stellate cells enhanced tumor progression
    Galli, A
    Ceni, E
    Mello, T
    Salzano, R
    Manta, R
    Surrenti, C
    Casini, A
    GASTROENTEROLOGY, 2002, 122 (04) : A488 - A488
  • [9] PYCR1 expresses in cancer-associated fibroblasts and accelerates the progression of C6 glioblastoma
    Zhang, Mingkun
    Bi, Baibin
    Liu, Guangcun
    Fan, Xiaoyong
    HISTOLOGY AND HISTOPATHOLOGY, 2025, 40 (01) : 89 - 100
  • [10] Ferritin heavy chain, FTH1, reduces p53 expression and contributes to pancreatic ductal adenocarcinoma progression
    Chiu, Ching-Feng
    Park, Ji Min
    Hung, Shao-Wen
    Chiu, Chien-Chao
    Chen, Hsin-An
    Huang, Ming-Te
    CANCER SCIENCE, 2021, 112 : 759 - 759
12345